In this technically savvy role, the CAS instructs customers on the Diopsys® NOVA Vision Testing System’s software, the technology of electrophysiology, Visual Evoked Potential (VEP), and the clinical implementation of the device.
Pine Brook, NJ (PRWEB) December 20, 2012
Diopsys, Inc., the leading provider of office-based electrophysiological vision testing devices, is expanding its Clinical Support Services Division. The company has grown rapidly over the last few years as optometrists and ophthalmologists continue to add advanced Visual Evoked Potential (VEP) vision testing to their practices. In order to meet the growing demand, Diopsys will add Clinical Application Specialists in Florida, Minnesota, North Carolina, South Carolina, and Texas.
According to Frank Taranto, Jr., Director of Clinical Support Service for Diopsys, the role of Clinical Application Specialist (CAS) is very education oriented. “In this technically savvy role, the CAS instructs customers on the Diopsys® NOVA Vision Testing System’s software, the technology of electrophysiology, Visual Evoked Potential (VEP), and the clinical implementation of the device.”
Diopsys’ comprehensive training and education process for practices gives doctors and practice staff a strong understanding of the science, technology and testing procedures for maximum clinical utility. In addition to the CAS training, Diopsys also offers further education in the form of bi-monthly webinars, user group meetings, and the Diopsys® VEP Case Review Program. The case review program is intended to assist NOVA-VEP users in developing a better understanding of how VEP fits into the diagnostic process for each patient.
Diopsys hopes to be able to hire the additional CAS members within the next few months. Details on all open career opportunities with Diopsys can be found at diopsys.com/careers.
Diopsys, Inc. (http://www.diopsys.com/) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care solutions. The company specializes in the development and marketing of patient-friendly, non-invasive vision testing equipment utilizing electrophysiological technology, including Visual Evoked Potential (VEP) technology.
Diopsys has developed and markets the patented Diopsys® NOVA-VEP Vision Testing Systems utilized by optometrists and ophthalmologists to help in the detection, diagnosis and treatment of vision disorders, including glaucoma. Diopsys also provides the Enfant® Pediatric VEP Vision Testing System, a device used in testing for visual deficits, including amblyopia, in children as young as six months of age.